Pfizer tests drug interaction in small safety study
NCT ID NCT06897683
Summary
This early-stage study aimed to understand how carbamazepine, an existing medication, changes how the body processes an experimental drug called PF-07220060. It involved 14 healthy adults who took both drugs in a specific sequence. Researchers measured drug levels in the blood to see if carbamazepine speeds up or slows down the breakdown of the new drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.